Gilead Sciences reported $3.21B in Pre-Tax Profit for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acorda Therapeutics ACOR:US $ -28.7M 9.15M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Eli Lilly And LLY:US $ 1988.6M 80.6M
GlaxoSmithKline GSK:LN 1482M 225M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Johnson & Johnson JNJ:US $ 7776M 515M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Sanofi SAN:FP € 2180M 376M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
United Therapeutics UTHR:US $ 216.5M 184M
YTE INCY:US $ 199.6M 31.06M